Reversible lymph node follicular hyperplasia associated with dasatinib treatment of chronic myeloid leukemia in chronic phase

Blood. 2013 Oct 24;122(17):3082-4. doi: 10.1182/blood-2013-07-513879.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents / adverse effects*
  • Chronic Disease
  • Dasatinib
  • Drug Administration Schedule
  • Drug Substitution
  • Humans
  • Hyperplasia / chemically induced*
  • Hyperplasia / pathology
  • Karyotyping
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology
  • Lymph Nodes / drug effects
  • Lymph Nodes / pathology*
  • Middle Aged
  • Protein Kinase Inhibitors / adverse effects*
  • Pyrimidines / adverse effects*
  • Thiazoles / adverse effects*

Substances

  • Antineoplastic Agents
  • Protein Kinase Inhibitors
  • Pyrimidines
  • Thiazoles
  • Dasatinib